45.12
price down icon1.66%   -0.76
 
loading
Disc Medicine Inc stock is traded at $45.12, with a volume of 274.28K. It is down -1.66% in the last 24 hours and down -2.25% over the past month. Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$45.88
Open:
$45.73
24h Volume:
274.28K
Relative Volume:
0.66
Market Cap:
$1.56B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-12.29
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
-7.71%
1M Performance:
-2.25%
6M Performance:
-30.10%
1Y Performance:
+30.18%
1-Day Range:
Value
$44.85
$47.25
1-Week Range:
Value
$44.85
$49.93
52-Week Range:
Value
$30.82
$68.73

Disc Medicine Inc Stock (IRON) Company Profile

Name
Name
Disc Medicine Inc
Name
Phone
(617) 674-9274
Name
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Name
Employee
84
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
IRON's Discussions on Twitter

Compare IRON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IRON
Disc Medicine Inc
45.12 1.69B 0 -91.00M -74.38M -3.67
Biotechnology icon
ONC
Beigene Ltd Adr
240.41 25.57B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.10 111.79B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 39.90M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.85 65.28B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.93 6.31B 0 -153.72M -103.81M -2.00

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-27-25 Initiated TD Cowen Buy
Nov-05-24 Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-04-24 Upgrade Raymond James Outperform → Strong Buy
Oct-23-24 Initiated Jefferies Buy
Oct-16-24 Initiated Scotiabank Sector Outperform
Aug-22-24 Initiated Wells Fargo Overweight
Apr-01-24 Downgrade Raymond James Strong Buy → Outperform
Dec-19-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-09-23 Upgrade Raymond James Outperform → Strong Buy
Jun-07-23 Initiated H.C. Wainwright Buy
May-17-23 Initiated Raymond James Outperform
Apr-28-23 Initiated Cantor Fitzgerald Overweight
Apr-21-23 Initiated Stifel Buy
Apr-20-23 Initiated Morgan Stanley Overweight
Mar-23-23 Initiated BMO Capital Markets Outperform
Feb-28-23 Initiated SVB Securities Outperform
View All

Disc Medicine Inc Stock (IRON) Latest News

pulisher
May 28, 2025

Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Disc Medicine Sets Double Conference Appearance: Jefferies and Goldman Sachs Healthcare Events - Stock Titan

May 28, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Invests $324,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

May 27, 2025
pulisher
May 27, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Stock Position Raised by Deutsche Bank AG - Defense World

May 27, 2025
pulisher
May 24, 2025

Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus

May 24, 2025
pulisher
May 23, 2025

Disc Medicine’s chief medical officer sells $334,128 in stock By Investing.com - Investing.com Canada

May 23, 2025
pulisher
May 22, 2025

Disc Medicine’s chief medical officer sells $334,128 in stock - Investing.com

May 22, 2025
pulisher
May 19, 2025

Porphyria Pipeline 2025: Groundbreaking Clinical - openPR.com

May 19, 2025
pulisher
May 17, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 15, 2025

Commit To Buy Disc Medicine At $35, Earn 14.1% Annualized Using Options - Nasdaq

May 15, 2025
pulisher
May 14, 2025

Disc Medicine Announces Multiple Presentations Across Portfolio - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Disc Medicine, Inc. to Present Key Data from Hematology Portfolio at EHA 2025 Congress - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Disc Medicine Announces Multiple Presentations Across - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Disc Medicine Reveals First Disease-Modifying EPP Treatment Data Among 6 Clinical Updates at EHA 2025 - Stock Titan

May 14, 2025
pulisher
May 14, 2025

BMO Capital Markets Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - Defense World

May 14, 2025
pulisher
May 13, 2025

Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Tower Research Capital LLC TRC Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

May 13, 2025
pulisher
May 12, 2025

How To Trade (IRON) - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

Disc Medicine (IRON) Price Target Raised by BMO Capital | IRON S - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Promising Outlook for Disc Medicine’s DISC-0974 in Anemia Treatment Justifies Buy Rating - TipRanks

May 12, 2025
pulisher
May 12, 2025

BMO Capital Boosts Price Target for Disc Medicine (IRON) to $120 - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Cantor Fitzgerald Comments on Disc Medicine FY2025 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 EPS Estimates for Disc Medicine Cut by Leerink Partnrs - Defense World

May 12, 2025
pulisher
May 11, 2025

Insider Sellers Might Regret Selling Disc Medicine Shares at a Lower Price Than Current Market Value - simplywall.st

May 11, 2025
pulisher
May 11, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 11, 2025
pulisher
May 10, 2025

Wedbush Issues Negative Forecast for Disc Medicine Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 09, 2025
pulisher
May 09, 2025

Disc Medicine Reports Strong Q1 2025 Progress - TipRanks

May 09, 2025
pulisher
May 08, 2025

Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Market Resilience: Disc Medicine Inc (IRON) Finishes Weak at 42.58, Down -12.40 - DWinneX

May 07, 2025
pulisher
May 07, 2025

Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Disc Medicine reports Q1 EPS ($1.02), consensus ($1.07) - TipRanks

May 07, 2025
pulisher
May 07, 2025

Disc Medicine, Inc. SEC 10-Q Report - TradingView

May 07, 2025
pulisher
May 07, 2025

Disc Medicine Inc (IRON) Reports Q1 2025 EPS of -$1.02, Aligns with Estimates; Strong Cash Position of $694.7 Million - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Disc's Bitopertin Program Advances with APOLLO Trial Launch | IRON Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Disc Medicine, Inc. Reports Q1 2025 Financial Results and Updates on Bitopertin and Pipeline Programs - Nasdaq

May 07, 2025
pulisher
May 03, 2025

Invesco Ltd. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

May 03, 2025
pulisher
May 02, 2025

(IRON) On The My Stocks Page - news.stocktradersdaily.com

May 02, 2025
pulisher
Apr 29, 2025

Wells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 29, 2025
pulisher
Apr 29, 2025

Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF) - The Manila Times

Apr 29, 2025
pulisher
Apr 29, 2025

Leading Cancer Centers Join Forces to Review Breakthrough Myelofibrosis Anemia Treatment Data - Stock Titan

Apr 29, 2025
pulisher
Apr 21, 2025

JPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 21, 2025
pulisher
Apr 21, 2025

Renaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 21, 2025
pulisher
Apr 17, 2025

When (IRON) Moves Investors should Listen - news.stocktradersdaily.com

Apr 17, 2025
pulisher
Apr 17, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Geode Capital Management LLC - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

New GlyT-1 inhibitors disclosed in Disc Medicine patent - BioWorld MedTech

Apr 15, 2025
pulisher
Apr 14, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald - MSN

Apr 13, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Has $67.73 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Apr 11, 2025

Disc Medicine Inc Stock (IRON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.05
price down icon 8.70%
$30.28
price down icon 2.39%
$576.24
price down icon 0.61%
$285.56
price down icon 1.56%
$4.35
price up icon 1.64%
$73.93
price down icon 2.22%
Cap:     |  Volume (24h):